Arrhythmogenic Right Ventricular Cardiomyopathy Clinical Trials
3 recruiting trials for Arrhythmogenic Right Ventricular Cardiomyopathy. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT06311708
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9)...
This is a multicenter, non-interventional study to observe the natural progression of the disease and to study the prevalence of pre-existing antibodies to AAV9 used for gene...
Sponsor: Tenaya TherapeuticsEnrolling: 20020 locations
RECRUITINGNCT06040242
Arrhythmogenic Activity During Exercise in ARVC Patients
Current guidelines advocate that ARVC patients, typically young and active individuals with a significant history of competitive endurance sports, cease endurance training in...
Sponsor: Swiss Federal Institute of TechnologyEnrolling: 1201 location
RECRUITINGNCT03049254
Mayo AVC Registry and Biobank
Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest...
Sponsor: Mayo ClinicEnrolling: 10002 locations